Evidence map›Paper›PMID 35466510›Full record

ReviewJournal of cosmetic dermatology2022

Mobile shopping beauty live commerce changes in COVID-19 pandemic focused on fun contents of MZ generation in Republic of Korea.

Jinkyung Lee, Ki Han Kwon

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cosmetic dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jinkyung LeeDivision of Beauty Arts Care, Department of Practical Arts, Graduate School of Culture and Arts, Dongguk University, Seoul, Republic of Korea.
Ki Han KwonCollege of General Education, Kookmin University, Seoul, Republic of Korea.
Amorepacific (South Korea) · KRKookmin University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the new virus responsible for the coronavirus disease 2019 (COVID-19) pandemic. According to these circumstances, a study was conducted to prepare a long-term non-face-to-face outpatient treatment service during the COVID-19 pandemic. Given the current situation of the times, it is expected that there will be no return to the non-face-to-face prior.

objectivesTherefore, this study descriptively investigated changes in consumer demand for new changes in the cosmetic market that has changed since COVID-19.

methodsIt was written with reference to keywords such as "Covid Mobile Shopping," "Covid MZ Generation," "Covid Live Commerce," and "Fun Content." This study was conducted by searches on PubMed, Google Scholar and Scopus, and ResearchGate. A total of 398 papers were found, of which 40 were successfully included in this study.

resultsIt is expected that this era will be centered on the MZ generation, which has emerged as a new consumer in the market, where individual tastes and individuality are emphasized. Millennials and Generation Z, also called the "SNS generation," are focusing on consumption trends.

conclusionIt is expected that this review will be used as important marketing material for a new change in the cosmetics market by clearly understanding the consumer needs of the cosmetics industry that has changed in the untact era.

Indexed as

COVID-19PandemicsBeautyCommerceHumansRepublic of KoreaSARS-CoV-2COVID-19Funlive commercemobile shoppingMZ generation

Identifiers

PMID35466510
PMCPMC9115095
OpenAlexW4224315499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.